Callahan Advisors, LLC Bristol Myers Squibb CO Transaction History

Callahan Advisors, LLC

$986 Million
Q3 2024

A detailed history of Callahan Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Callahan Advisors, LLC holds 6,714 shares of BMY stock, worth $387,263. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,714

Previous 5,780 16.16%

Holding current value

$387,263

Previous $240,000 44.58%

% of portfolio

0.04%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$39.66 - $51.75 $37,042 - $48,334	934 Added 16.16%	6,714 $347,000
Q2 2024 Jul 29, 2024	BUY	$40.25 - $52.99 $54,176 - $71,324	1,346 Added 30.36%	5,780 $240,000
Q1 2024 Apr 24, 2024	BUY	$47.98 - $54.4 $212,743 - $241,209	4,434 New	4,434 $240,000
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $2.77 Million - $3.1 Million	-47,818 Reduced 68.47%	22,017 $1.28 Million
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $1.59 Million - $1.77 Million	-25,034 Reduced 26.39%	69,835 $4.47 Million
Q1 2023 Apr 28, 2023	SELL	$65.71 - $74.53 $257,057 - $291,561	-3,912 Reduced 3.96%	94,869 $6.58 Million
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $139,699 - $165,423	2,040 Added 2.11%	98,781 $7.11 Million
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $1,401 - $828,565	10,783 Added 12.54%	96,741 $6.88 Million
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $237,685 - $261,774	3,273 Added 3.96%	85,958 $6.62 Million
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $264,732 - $317,438	4,306 Added 5.49%	82,685 $6.04 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $1.6 Million - $1.86 Million	-29,813 Reduced 27.56%	78,379 $4.89 Million
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $291,175 - $341,074	4,921 Added 4.77%	108,192 $6.4 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $778,518 - $847,806	12,575 Added 13.86%	103,271 $6.9 Million
Q1 2021 Apr 21, 2021	BUY	$59.34 - $66.74 $1.29 Million - $1.45 Million	21,696 Added 31.44%	90,696 $5.73 Million
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $2.07 Million - $2.35 Million	35,858 Added 108.2%	69,000 $4.28 Million
Q3 2020 Oct 26, 2020	BUY	$57.43 - $63.64 $1.9 Million - $2.11 Million	33,142 New	33,142 $2 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Callahan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callahan Advisors, LLC with notifications on news.

Account

Callahan Advisors, LLC Bristol Myers Squibb CO Transaction History